Irritable Bowel Syndrome (ibs) - Pharma

Relevant Publications

Butyrate promotes visceral hypersensitivity in IBS model via mast cell-derived DRG neuron lincRNA-01028-PKC-TRPV1 pathway.

Issue Release: 2024

Dectin-1 induces TRPV1 sensitization and contributes to visceral hypersensitivity of irritable bowel syndrome in male mice.

Issue Release: 2024

Immune cell signatures and causal association with irritable bowel syndrome: A mendelian randomization study.

Issue Release: 2024

Irritable bowel syndrome in children: the placebo response rate and influencing factors a meta-analysis.

Issue Release: 2024

Rome III and IV criteria are less discordant to diagnose irritable bowel syndrome in clinic patients than in community subjects.

Issue Release: 2024

Efficacy of acupuncture in refractory irritable bowel syndrome patients: a randomized controlled trial.

Issue Release: 2024

Challenges of recruitment processes to a randomized dietary trial in irritable bowel syndrome.

Issue Release: 2024

Comparison of digitally-delivered gut-directed hypnotherapy program to an active control for irritable bowel syndrome.

Issue Release: 2024

miR-155 and miR-21 as Diagnostic and Therapeutic Biomarkers for Ulcerative Colitis: There Is Still a Long Way to Go.

Issue Release: 2024

Tea-derived exosome-like nanoparticles prevent irritable bowel syndrome induced by water avoidance stress in rat model.

Issue Release: 2024

Review of the Patient Burden and Therapeutic Landscape of Irritable Bowel Syndrome with Constipation in the United States.

Issue Release: 2024

Management of gastrointestinal stromal tumor and acute appendicitis during pregnancy: A case report.

Issue Release: 2024

Effect of the combined intervention of low-FODMAPs diet and probiotics on IBS symptoms in Western China: A randomized controlled trial.

Issue Release: 2024

Is the Mediterranean Low Fodmap Diet Effective in Managing Irritable Bowel Syndrome Symptoms and Gut Microbiota? An Innovative Research Protocol.

Issue Release: 2024

Changes in Fecal Short-Chain Fatty Acids in IBS Patients and Effects of Different Interventions: A Systematic Review and Meta-Analysis.

Issue Release: 2024

Gut-directed hypnosis and hypnotherapy for irritable bowel syndrome: a mini-review.

Issue Release: 2024

Incidence of menstrual symptoms suggestive of possible endometriosis in adolescents: and variance in these by ethnicity and socio-economic status.

Issue Release: 2024

Alterations in gastrointestinal motility assessed by high-resolution antroduodenal manometry in patients with severe disorders of gut-brain interaction.

Issue Release: 2024

Current and future pharmacotherapies for the management of constipation-predominant irritable bowel syndrome.

Issue Release: 2024

Fructose malabsorption and fructan malabsorption are associated in patients with irritable bowel syndrome.

Issue Release: 2024

Which Agencies are Involved?

What Are the Therapeutic Approaches to Mitigate Cellular Stress?

How Does Cellular Stress Impact Drug Development?

How Do Pharmacists Contribute to Patient Care?

What are the Challenges in Implementing Collaborative Care Models?

Why is Medication Adherence Important?

What Roles Do Pharmacists Play in Pharma?

How Can ADEs be Prevented?

How Can Technology Aid in Patient Education?

What are Chronic Conditions?

Partnered Content Networks

Relevant Topics